

Analysts raised targets for ACN, SYNA, ATRC and MPC; cut targets for CSX, NKE, MKC and FHTX, with ATRC downgraded to Hold.
You can purchase shares of Shattuck Labs (NASDAQ:STTK) through any online brokerage.
Other companies in Shattuck Labs’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Shattuck Labs has a consensus price target of $15.67.
The stock price for Shattuck Labs (NASDAQ: STTK) is $5.72 last updated October 29, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Shattuck Labs.
Shattuck Labs does not have any upcoming earnings scheduled.
There is no upcoming split for Shattuck Labs.
Shattuck Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease...